☰

Dima Sabbah, Ph.D. - Publications

Affiliations: 
2012 Pharmaceutical Studies University of Nebraska Medical Center, Omaha, NE, United States 
Area:
Pharmacy, Pharmaceutical Chemistry, Biochemistry
Tree Info Similar researchers PubMed Report error

18 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2022 Bardaweel S, Aljanabi R, Sabbah D, Sweidan K. Design, Synthesis, and Biological Evaluation of Novel MAO-A Inhibitors Targeting Lung Cancer. Molecules (Basel, Switzerland). 27. PMID 35566238 DOI: 10.3390/molecules27092887  0.338
2021 Sabbah DA, Al-Azaideh BA, Talib WH, Hajjo R, Sweidan K, Al-Zuheiri AM, Sheikha GA, Shraim S. New derivatives of sulfonylhydrazone as potential antitumor agents: Design, synthesis and cheminformatics evaluation. Acta Pharmaceutica (Zagreb, Croatia). 71: 545-565. PMID 36651560 DOI: 10.2478/acph-2021-0043  0.34
2021 Sabbah DA, Hajjo R, Bardaweel SK, Zhong HA. Phosphatidylinositol 3-kinase (PI3K) inhibitors: a recent update on inhibitor design and clinical trials (2016-2020). Expert Opinion On Therapeutic Patents. 1-16. PMID 33970742 DOI: 10.1080/13543776.2021.1924150  0.338
2020 Sabbah DA, Haroon RA, Bardaweel SK, Hajjo R, Sweidan K. -Phenyl-6-Chloro-4-Hydroxy-2-Quinolone-3-CarboxAmides: Molecular Docking, Synthesis, and Biological Investigation as Anticancer Agents. Molecules (Basel, Switzerland). 26. PMID 33375766 DOI: 10.3390/molecules26010073  0.313
2018 Khalaf RA, Masalha D, Sabbah D. DPP-IV Inhibitory Phenanthridines: Ligand, Structure-Based Design, and Synthesis. Current Computer-Aided Drug Design. PMID 30526469 DOI: 10.2174/1573409915666181211114743  0.389
2018 Abu Khalaf RA, Sabbah D, Al-Shalabi E, Al-Sheikh I, Albadawi G, Abu Sheikha G. Synthesis, Structural Characterization and Docking Studies of Sulfamoyl-Phenyl Acid Esters as DPP-IV Inhibitors. Current Computer-Aided Drug Design. PMID 29521244 DOI: 10.2174/1573409914666180308164013  0.308
2017 Abu Khalaf R, Sabbah D, Al-Shalabi E, Bishtawi S, Albadawi G, Abu Sheikha G. Synthesis, Biological Evaluation, and Molecular Modeling Study of Substituted Benzyl Benzamides as CETP Inhibitors. Archiv Der Pharmazie. PMID 29112287 DOI: 10.1002/Ardp.201700204  0.417
2017 Sabbah DA, Sweidan K. Molecular Docking Studies of Novel Thiosemicarbazone-based Indoles as Potential PI3Kα Inhibitors Letters in Drug Design & Discovery. 14. DOI: 10.2174/1570180814666170619112647  0.319
2017 Sweidan K, Sabbah DA, Bardaweel S, Abu Sheikha G, Al-Qirim T, Salih H, El-Abadelah MM, Mubarak MS, Voelter W. Facile synthesis, characterization, and cytotoxicity study of new 3-(indol-2-yl)bicyclotetrazatridecahexaens Canadian Journal of Chemistry. 95: 858-862. DOI: 10.1139/Cjc-2017-0120  0.346
2016 Sweidan K, Sabbah DA, Bardaweel S, Dush KA, Sheikha GA, Mubarak MS. Computer-aided design, synthesis, and biological evaluation of new indole-2-carboxamide derivatives as PI3Kα/EGFR inhibitors. Bioorganic & Medicinal Chemistry Letters. PMID 27084677 DOI: 10.1016/J.Bmcl.2016.04.011  0.343
2015 Sabbah DA, Saada M, Khalaf RA, Bardaweel S, Sweidan K, Al-Qirim T, Al-Zughier A, Halim HA, Sheikha GA. Molecular modeling based approach, synthesis, and cytotoxic activity of novel benzoin derivatives targeting phosphoinostide 3-kinase (PI3Kα). Bioorganic & Medicinal Chemistry Letters. 25: 3120-4. PMID 26099539 DOI: 10.1016/J.Bmcl.2015.06.011  0.41
2015 Sweidan K, Sabbah DA, Engelmann J, Abdel-Halim H, Sheikha GA. Computational docking studies of novel heterocyclic carboxamides as potential PI3Kα inhibitors Letters in Drug Design and Discovery. 12: 856-863. DOI: 10.2174/1570180812666150529205248  0.377
2015 Abu Khalaf R, Jarekji Z, Al-Qirim T, Sabbah D, Shattat G. Pharmacophore modeling and molecular docking studies of acridines as potential DPP-IV inhibitors Canadian Journal of Chemistry. 93: 721-729. DOI: 10.1139/Cjc-2015-0039  0.408
2012 Sabbah DA, Vennerstrom JL, Zhong HA. Binding selectivity studies of phosphoinositide 3-kinases using free energy calculations. Journal of Chemical Information and Modeling. 52: 3213-24. PMID 23157418 DOI: 10.1021/Ci3003057  0.509
2012 Sabbah DA, Simms NA, Wang W, Dong Y, Ezell EL, Brattain MG, Vennerstrom JL, Zhong HA. N-Phenyl-4-hydroxy-2-quinolone-3-carboxamides as selective inhibitors of mutant H1047R phosphoinositide-3-kinase (PI3Kα). Bioorganic & Medicinal Chemistry. 20: 7175-83. PMID 23121722 DOI: 10.1016/J.Bmc.2012.09.059  0.548
2012 Sabbah DA, Simms NA, Brattain MG, Vennerstrom JL, Zhong H. Biological evaluation and docking studies of recently identified inhibitors of phosphoinositide-3-kinases. Bioorganic & Medicinal Chemistry Letters. 22: 876-80. PMID 22212721 DOI: 10.1016/J.Bmcl.2011.12.044  0.573
2011 Sabbah DA, Brattain MG, Zhong H. Dual inhibitors of PI3K/mTOR or mTOR-selective inhibitors: Which way shall we go? Current Medicinal Chemistry. 18: 5528-5544. PMID 22172063  0.336
2010 Sabbah DA, Vennerstrom JL, Zhong H. Docking studies on isoform-specific inhibition of phosphoinositide-3-kinases. Journal of Chemical Information and Modeling. 50: 1887-98. PMID 20866085 DOI: 10.1021/Ci1002679  0.55
Show low-probability matches.